UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder

Abstract Aim This study aims to analyze the health‐related quality of life (HRQoL) and safety outcomes in attention‐deficit/hyperactivity disorder (ADHD) patients treated with cannabis‐based medicinal products (CBMPs). Methods Patients were identified from the UK Medical Cannabis Registry. Primary o...

Full description

Bibliographic Details
Main Authors: Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker, Mikael H. Sodergren
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Neuropsychopharmacology Reports
Subjects:
attention deficit disorder with hyperactivity
cannabidiol
cannabis
psychiatry
tetrahydrocannabinol
Online Access:https://doi.org/10.1002/npr2.12400

Internet

https://doi.org/10.1002/npr2.12400

Similar Items